Search

for
Search:

Sort by

Research

60-62 / 62 results

December 2022 in “International Journal of Molecular Sciences”

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

192 citations, January 2015 in “Journal of the American Academy of Dermatology”

Targeted cancer therapies often cause serious skin problems that need careful management.